Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 99 | ECE2024

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

Card image cap
We are pleased to announce that ECE 2024 will be held in Stockholm, Sweden from 11-14 May 2024. We will, once again, be offering the hybrid format next year so you can join us in person in Sweden or remotely with ECE@Home.

Rapid Communications

Rapid Communications 7: Endocrine-related Cancer

ea0099rc7.1 | Rapid Communications 7: Endocrine-related Cancer | ECE2024

PRAP study - Partial versus radical adrenalectomy for hereditary pheochromocytomas

Xu Kai , Langenhuijsen Johannes , Vietor Charlotte , Feelders Richard , van Ginhoven Tessa , Elhassan Yasir , Bioletto Fabio , Parasiliticaprino Mirko , Zandee Wouter , Kruijff Schelto , AEkerstrom Tobias , Pamporaki Christina , Bechmann Nicole , Lussey-Lepoutre Charlotte , Canu Letizia , Steenaard Rebecca , Driessens Natacha , Velema Marieke , Dreijerink Koen , Engelsman Anton , Timmers Henri , de Laat Marieke

Introduction: Pheochromocytoma, a rare catecholamine-secreting adrenal tumor, can cause hypertension and life-threatening complications. Hereditary cases have an increased risk of developing bilateral disease. Standard treatment involves radical adrenalectomy, leading to adrenal insufficiency in bilateral cases. Partial adrenalectomy aims to preserve adrenal function but has higher recurrence rates. This study compares outcomes of partial vs radical adrenalectomy in hereditary...

ea0099rc7.2 | Rapid Communications 7: Endocrine-related Cancer | ECE2024

The presence of abortive changes in thyroid tumors serves as a strong indicator of underlying DICER1 mutations

Condello Vincenzo , Roberts James , Stenman Adam , Larsson Catharina , Viswanathan Kartik , Juhlin Christofer

Background: Somatic and bi-allelic DICER1 mutations have been reported in subsets of sporadic thyroid tumors, affirming a clear involvement of this gene in the development of thyroid tumors. As a recent study has highlighted associations between DICER1 mutations and macrofollicular patterns, abortive changes, and papillary structures, we aimed to investigate these observations in a bi-institutional cohort.Methods: A total of 61 thyroid lesions (...

ea0099rc7.3 | Rapid Communications 7: Endocrine-related Cancer | ECE2024

Activating the intratumoral IFNγR-pathway in adrenocortical carcinoma potently enhances antitumor functionality of CAR-T cells by modulating immune cell adhesion and responsiveness

Schauer Marc Philipp , Landwehr Laura-Sophie , Weber Justus , Altieri Barbara , Sbiera Silviu , Kroiss Matthias , Fassnacht Martin , Hudecek Michael

Background: Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine disease in which 60% of patients show endogenous glucocorticoid (GC) secretion that potentially contributes to a lack of immune cell infiltration and limited efficacy of immunotherapeutic approaches. In another study, we already demonstrated potent antitumor efficacy or ROR1 CAR-T cells in preclinical models of ACC. Nevertheless, solid tumors often show cell intrinsic resistance mechanisms to CAR-T c...

ea0099rc7.4 | Rapid Communications 7: Endocrine-related Cancer | ECE2024

Decrease in anticortisolic drmg osilodrostat plasma exposure in patients treated with mitotane for adrenocortical carcinoma

Thomeret Louis , Puszkiel Alicja , Balakirouchenane David , Bouys Lucas , Poirier Jonathan , Berthon Annabel , Ragazzon Bruno , Jouinot Anne , Guignat Laurence , Bessiene Laura , Libe Rossella , Bricaire Leopoldine , Leguy Marie-Clemence , Guibourdenche Jean , Groussin-Rouiller Lionel , Assie Guillaume , Blanchet Benoit , Bertherat Jerome , Bonnet-Serrano Fideline

Introduction: The steroidogenesis inhibitor osilodrostat (OSI), indicated for the medical treatment of endogenous Cushing’s syndrome, exhibits significant interindividual variability regarding the response to treatment (Pivonello et al., 2020), a fortiori in the context of adrenocortical carcinoma (Tabarin et al., 2022). Plasma exposure may contribute to this variability. Our objective was to investigate the effect of concomita...

ea0099rc7.5 | Rapid Communications 7: Endocrine-related Cancer | ECE2024

Fibroblast-mediated modulation of GI-NETs: Implications for drmg response and tumor invasion

Malavasi Eleonora , Toffoli Lara , Dainotto Marilyn , Ditsiou Angeliki , Gagliano Teresa

Introduction: The intricate interplay between fibroblasts and cancer cells significantly contributes to cancer invasion, extracellular matrix (ECM) modulation, and the development of drmg resistance. This study delves into understanding the specific influence of fibroblasts on Gastro-Intestinal neuroendocrine tumor (GI-NET) cell lines.Materials and Methods: Utilizing GOT1 and COLO320 cell lines, we incorporated Normal Human Dermal Fibroblasts (NF) in our...

ea0099rc7.6 | Rapid Communications 7: Endocrine-related Cancer | ECE2024

The expression and prognostic value of somatostatin and glucagon-like peptide 1 receptors in insulinoma

Peltola Elina , Vesterinen Tiina , Leijon Helena , Hannula Paivi , Huhtala Heini , Makinen Markus , Nieminen Lasse , Pirinen Elina , Ronty Mikko , Soderstrom Mirva , Arola Johanna , Jaatinen Pia

Insulinomas are rare insulin-producing pancreatic neuroendocrine tumours. Most insulinomas are non-metastatic and can be cured by surgery, but in 10% of the patients insulinomas metastasize, which is associated with a significantly impaired overall survival. As the metastatic potential of an insulinoma cannot be reliably predicted with the current biomarkers, we aimed to evaluate the expression of somatostatin receptors (SSTRs) and glucagon-like peptide-1 receptors (GLP-1Rs) i...